Paris, France

René Lafont

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor René Lafont

Introduction

René Lafont is a notable inventor based in Paris, France. He has made significant contributions to the field of biomedical research, particularly in the treatment of neuromuscular diseases. With a total of 9 patents to his name, Lafont's work has the potential to impact many lives.

Latest Patents

Lafont's latest patents include groundbreaking research on phytoecdysones and their derivatives for use in the treatment of neuromuscular diseases. This patent discloses 20-hydroxyecdysone and its derivatives, which are intended for treating conditions such as spinal muscular atrophy and amyotrophic lateral sclerosis. Another significant patent involves chemical compounds targeting the eye, specifically derivatives of norbixin that are aimed at treating eye diseases like age-related macular degeneration and Stargardt's disease.

Career Highlights

Throughout his career, Lafont has worked with prominent organizations such as Biophytis and Sorbonne Université. His research has focused on innovative solutions to complex medical challenges, showcasing his dedication to advancing healthcare.

Collaborations

Lafont has collaborated with esteemed colleagues, including Stanislas Veillet and Waly Dioh. These partnerships have further enriched his research and contributed to the development of his patents.

Conclusion

René Lafont's innovative work in the field of biomedical research exemplifies the impact that dedicated inventors can have on healthcare. His patents not only reflect his expertise but also hold promise for future advancements in treating neuromuscular and eye diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…